openPR Logo
Press release

Investigation announced for Investors in shares of Helios Technologies, Inc. (NYSE: HLIO) over possible Violations of Securities Laws

An investigation for investors in Helios Technologies, Inc. (NYSE: HLIO) shares over potential securities laws violations.

An investigation for investors in Helios Technologies, Inc. (NYSE: HLIO) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by Helios Technologies, Inc.

Investors who purchased shares of Helios Technologies, Inc. (NYSE: HLIO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Helios Technologies, Inc. (NYSE: HLIO) concerning whether a series of statements by Helios Technologies, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Sarasota, FL based Helios Technologies, Inc., together with its subsidiaries, provides engineered motion control and electronic control technology solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Helios Technologies, Inc. reported that its annual Total Revenue declined from $885.4 million in 2022 to $835.6 million in 2023, and that its Net Income declined from $98.4 million in 2022 to $37.5 million in 2023.

On July 9, 2024, Helios Technologies, Inc. formally announced that Josef Matosevic, who serves as the Company's President, Chief Executive Officer, and Director, was placed on an immediate paid leave, effective retroactively from July 1, 2024. This administrative action arose in response to allegations suggesting a potential violation of the Company's Code of Business Conduct and Ethics. The Company has initiated an internal investigation to thoroughly examine the circumstances surrounding these allegations.

Shares of Helios Technologies, Inc. (NYSE: HLIO) declined from $54.06 per share on May 20, 2024, to as low as $39.46 per share on July 09, 2024.

Those who purchased shares of Helios Technologies, Inc. (NYSE: HLIO) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Helios Technologies, Inc. (NYSE: HLIO) over possible Violations of Securities Laws here

News-ID: 3611278 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Helios

HELIOS White Paper Provides Options for Discontinued Apple Xserve
Demise of Apple Xserve worries admins - HELIOS white paper details migration options. Replication of key Apple technologies such as AFP file and print sharing for Macs, Spotlight search, Bonjour server, Time Machine backups, etc. is handled by HELIOS File Server Bundle, supporting Mac, Windows, and Web clients. Hannover, Germany - March 09, 2011 -- HELIOS Software GmbH, a leading cross-platform file and print server developer, today issued a white paper
Helios Announces 5th Annual Apollo Award Finalists
March 7, 2011 - Reston, Va. - Helios, a provider of human capital management solutions that optimize workforce and business operations, today announced the 20 finalists of the 2011 Helios Apollo Awards. In its fifth year, the Apollo Awards program is the premier award program for recognizing employers in the Washington metropolitan region that invest in innovative employee development initiatives. “As we celebrate the Apollo Awards’ 5th anniversary, we are honored
HELIOS White Paper Offers Options for Discontinued Apple Xserve
Demise of Apple Xserve worries admins - HELIOS white paper details migration options. Replication of key Apple technologies such as AFP file and print sharing for Macs, Spotlight search, Bonjour server, Time Machine backups, etc. is handled by HELIOS File Server Bundle, supporting Mac, Windows, and Web clients. Hannover, Germany, March 07, 2011 (Straight Line PR) -- HELIOS Software GmbH, a leading cross-platform file and print server developer, today issued a
HELIOS White Paper Details Options for Discontinued Apple Xserve
Demise of Apple Xserve worries admins - HELIOS white paper details migration options. Replication of key Apple technologies such as AFP file and print sharing for Macs, Spotlight search, Bonjour server, Time Machine backups, etc. is handled by HELIOS File Server Bundle, supporting Mac, Windows, and Web clients. Hannover, Germany, March 01, 2011 -- HELIOS Software GmbH, a leading cross-platform file and print server developer, today issued a white paper detailing
HELIOS White Paper Details Options for Discontinued Apple Xserve
Demise of Apple Xserve worries admins - HELIOS white paper details migration options. Replication of key Apple technologies such as AFP file and print sharing for Macs, Spotlight search, Bonjour server, Time Machine backups, etc. is handled by HELIOS File Server Bundle, supporting Mac, Windows, and Web clients. Hannover, Germany - February 23, 2011 -- HELIOS Software GmbH, a leading cross-platform file and print server developer, today issued a white paper
Upcoming HELIOS UB2 Software with Enhanced PDF Support
HELIOS PDF HandShake UB2 integrates enhanced PDF preflight features of callas pdfToolbox 4, adds support for Acrobat Distiller X on Mac and Windows to Create PDF Server, enhances PDF compatibility and preview rendering, and introduces full text searching capabilities. Hannover, Germany, January 23, 2011 (Straight Line PR) -- HandShake UB2, from HELIOS Software, will include many new and updated features to make PDF creation, preflighting, searching, and printing more productive for